For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Why don’t they take their meds? Thinking small and from the bottom up may help
+Print Archive
News
Why don’t they take their meds? Thinking small and from the bottom up may help
Wednesday 8 May 2019, 09:00 AM

There could be a Tongan solution to insulin usage reluctance, says Glenn Doherty
Alan Perrott takes a look at an 18-month Whakakotahi partnership between Auckland’s Tongan Health Society, the Health Quality & Safety Commission and Pharmac trialling an innovative approach to diabetes treatment
Access issues prevented Māori from receiving one million funded medication treatments
The drugs are there, and the delivery tools are readily av
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.